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Vascular calcification is associated with an adverse prognosis
in end-stage renal disease. It can be accurately quantitated
with computed tomography but simple in-office techniques
may provide equally useful information. Accordingly we
compared the results obtained with simple non-invasive
techniques with those obtained using electron beam
tomography (EBT) for coronary artery calcium scoring (CACS)
in 140 prevalent hemodialysis patients. All patients
underwent EBT imaging, a lateral X-ray of the lumbar
abdominal aorta, an echocardiogram, and measurement of
pulse pressure (PP). Calcification of the abdominal aorta was
semiquantitatively estimated with a score (Xr-score) of 0–24
divided into tertiles, echocardiograms were graded as 0–2 for
absence or presence of calcification of the mitral and aortic
valve and PP was divided in quartiles. The CACS was elevated
(mean 91071657, median 220). The sensitivity and specificity
for CACSX100 was 53 and 70%, for calcification of either
valve and 67 and 91%, respectively, for Xr-scoreX7. The area
under the curve for CACSX100 associated with valve
calcification and Xr-score was 0.62 and 0.78, respectively. The
likelihood ratio (95% confidence interval) of CACSX100 was
1.79 (1.09, 2.96) for calcification of either valve and 7.50 (2.89,
19.5) for participants with an Xr-score X7. In contrast, no
association was present between PP and CACS. In conclusion,
simple measures of cardiovascular calcification showed a very
good correlation with more sophisticated measurements
obtained with EBT. These methodologies may prove very
useful for in-office imaging to guide further therapeutic
choices in hemodialysis patients.
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Calcification of vessels and valves is highly prevalent in
maintenance hemodialysis patients and has been associated
with an increased risk of cardiovascular as well as all-cause
mortality.1 The extent of calcification can be accurately
quantified with sophisticated radiological techniques
such as electron beam tomography (EBT).2 In the general
population, calcium scores derived with EBT have been
shown to add incremental prognostic information to
traditional risk factors for the prediction of hard events.3–5
Similar but weaker evidence has been published in a
hemodialysis study.6 Sequential EBT scanning has also been
utilized to follow the progression of vascular and valvular
calcification in subjects with normal renal function as well as
uremic patients.7–10 Although quantitatively accurate, both
EBT and the more modern multidetector computed tomo-
graphy (CT) technologies are expensive, deliver a substantial
dose of radiation, and cannot be easily performed in an
ambulatory setting. As the presence of calcification has
important prognostic and therapeutic implications, the
Global Bone and Mineral Initiative11 recently proposed that
a series of simple in-office measurements and assessments
might be substituted for EBT and multidetector CT to
identify and semiquantitatively assess the extent of cardio-
vascular calcification in patients suffering from end-stage
renal disease. This group of experts suggested that a plain
lateral X-ray of the lumbar spine (Figure 1) to assess the
presence of calcification of the abdominal aorta,12 the
measurement of pulse pressure (PP),13 and the performance
of an echocardiogram to visualize calcification of the cardiac
valves14 might provide useful diagnostic and prognostic
information. These three techniques were therefore proposed
as a substitute for the more sophisticated and expensive CT
imaging tools because of their demonstrated prognostic
significance.11 Accordingly, the aim of this study was to
compare the information derived with EBT and simple in-
office approaches to demonstrate the presence and extent of
cardiovascular calcification in a cohort of prevalent hemo-
dialysis patients.
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RESULTS
Study population characteristics
Overall, there were an equal number of men and women.
Caucasians and African Americans were the most common
race-ethnicity groups (40 and 53%, respectively) with only
7% of other races. The mean dialysis vintage was 2.7 years
and hypertension and diabetes mellitus were highly prevalent
(95 and 50%, respectively). The mean (7s.d.) abdominal
aorta X-ray score was 4.475.7 (median 1, inter-quartile
range 0–7). The mean systolic arterial pressure was elevated
at 146726 mmHg with a mean diastolic pressure of
78714.5 mmHg and a mean PP of 57718 mmHg.
On EBT imaging, 24 patients did not have any coronary
artery calcium and 18 had a coronary artery calcium score
(CACS)o30. The distribution of CACS categories in the
study population is shown in Figure 2. The median CACS
was high (220; inter-quartile range 19–899). Table 1 shows the
clinical characteristics of the study population according to
CACS categories. On average, participants with higher
coronary artery scores were older, more likely to have a
history of atherosclerotic cardiovascular disease, and had
higher abdominal aorta X-ray scores.
Figure 3 shows the prevalence of valvular calcification
identified by echocardiography in patients categorized
according to various CACS thresholds. Figure 4 shows the
prevalence of various levels of CACS by quartile of PP and
abdominal aorta X-ray score. Patients with mitral and aortic
valve calcification and higher abdominal aorta X-ray scores
were consistently more likely to have higher CACSs.
Test properties of non-CT tools
Table 2 show the sensitivity, specificity, likelihood ratios, and
area under the curve for PP, valve calcification, and
abdominal aorta Xr scores in the prediction of CACSX30,
X100, X400, X1000. The presence and extent of valve
calcification and abdominal aorta calcification were asso-
ciated with progressively higher likelihood ratios of each
CACS category. For example, the likelihood ratio (95%
confidence interval) of CACSX100 for patients with 1 and 2
calcified valves was 1.79 (1.09, 2.96) and 1.88 (1.05, 3.39),
respectively, and 2.53 (1.49, 4.28) and 7.50 (2.89, 19.5) for
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Figure 1 | Example of lateral lumbar X-ray showing calcification
of the anterior (white arrow) and posterior wall (black arrow)
of the abdominal aorta.
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Figure 2 | Prevalence of coronary artery calcium score categories
among study participants.
Table 1 | Study population characteristics by coronary artery calcium score
Coronary artery calcium score on EBT
0–29 (n=42) 30–99 (n=16) 100–399 (n=27) 400–999 (n=26) X1000 (n=29) P-trend
Age (years) 46.7 (14.7) 54.8 (13.1) 56.6 (15.1) 62.5 (10.8) 60.5 (12.0) o0.001
Women (%) 58.1 56.3 50.0 46.4 45.5 0.119
African American (%) 53.5 62.5 46.4 50.0 54.6 0.864
Diabetes mellitus (%) 41.9 50.0 42.9 57.1 63.6 0.122
BMI (kg/m2) 26.5 (5.4) 26.8 (5.6) 26.0 (5.4) 26.1 (4.8) 27.1 (6.1) 0.880
Current smoking (%) 12.2 20.0 11.1 18.5 31.3 0.209
History of ASCVD (%) 14.0 43.8 39.3 67.9 45.5 o0.001
SBP (mmHg) 146.0 (23.1) 143.6 (22.4) 145.4 (29.5) 151.2 (26.3) 144.8 (26.3) 0.819
DBP (mmHg) 81.8 (15.7) 80.1 (12.4) 74.4 (15.2) 80.3 (12.9) 74.4 (14.1) 0.061
Pulse pressure (mmHg) 64.2 (16.4) 63.6 (19.7) 71.1 (26.7) 70.8 (21.4) 70.3 (20.4) 0.111
Abdominal aorta X-Ray score 0.90 (2.02) 2.19 (3.58) 5.37 (5.61) 6.62 (6.65) 7.66 (6.58) o0.001
Valvular calcification
Aortic valve (%) 33.3 25.0 29.6 53.9 75.9 o0.001
Mitral valve (%) 32.6 25.0 48.2 19.2 59.4 0.084
ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; DBP, diastolic blood pressure; EBT, electron beam tomography; SBP, systolic blood pressure.
Parentheses indicate s.d.
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patients with an abdominal aorta X-ray score of 1–6 andX7,
respectively. Additionally, the area under the curve for
abdominal Xr-scores was above 0.70 for predicting each
CACS level indicating very good discriminatory value. The
area under the curve for valve calcification increased from
0.58 for a CACSX30 to 0.72 for a CACSX1000 indicating
fair to good discriminatory value. In contrast, the test
properties for PP showed very low accuracy in predicting
CACS.
DISCUSSION
These results suggest that a meaningful association exists
between semiquantitative, office-based methods and sophis-
ticated and quantitative methods to assess the extent of
cardiovascular calcification. A strong association was present
between abdominal aorta calcification on plain X-ray films
and CACS. Also, valvular calcification was a good predictor
of CACS. On the contrary, no pattern was present between
PP and CACS.
Although an increased PP may be a risk factor for
unfavorable outcomes, it is likely a very remote surrogate
marker of vascular calcification and depends on many more
factors than vascular calcification alone. Furthermore, central
aortic pressure may reflect more accurately vascular stiffness –
and vascular calcification – and it is a an excellent marker of
risk in the renal15 as well the general population.16
Our study results highlight the potential for greater and
more global implementation of the kidney disease outcomes
quality initiative (K/DOQI) guidelines on management of
dialysis patients with cardiovascular calcifications that are
considered a marker of risk and an indication for changes in
therapeutic choices.17 Braun et al.18 were the first to utilize
EBT to describe the large extent of coronary artery and
valvular calcification in hemodialysis patients compared to
age- and sex-matched individuals with and without coronary
artery disease and intact renal function. Similar observations
were reported in young patients undergoing dialysis,19,20 and
in a larger series of adult subjects.21 Utilizing EBT, the
progression of valvular and vascular calcification was also
shown to be rapid18 and to be inhibited with the non-
calcium-based phosphate binder sevelamer.8–10 Given the
negative prognostic impact of cardiovascular calcification
and the possibility to slow its progression, the National
Kidney Foundation has recommended screening for its
presence with simple office-based methods to make it
accessible to a wider audience of practicing physicians.11
This study shows that widely available office techniques
may indeed be very helpful in assessing the presence of
CACS. Furthermore, these simpler techniques may be
appropriate for patients that are typically excluded from
cardiac CT imaging owing to arrhythmias and excessive
weight, although our investigation did not specifically
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Figure 3 | Prevalence of coronary artery calcium score X30, X100, X400, and X1000 for patients with and without mitral and
aortic valve calcification.
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Figure 4 | Prevalence of coronary artery calcium score X30, X100, X400, and X1000 by quartile of PP and level of abdominal
aorta calcification.
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address such populations. Nonetheless, CT remains a highly
reliable research tool and it is very useful in the proper
clinical context.
Of interest, there was no difference in severity of CACS
between white and black individuals, in contrast with recent
literature showing a smaller quantity of coronary artery
calcium in blacks, compared to whites, with normal renal
function.22 This suggests that hemodialysis may nullify any
racial difference as far as the extent of CACS is concerned,
probably due to processes that involve both medial as well as
sub-intimal calcification.
There were a few limitations to this study. The results of
our investigation should be considered preliminary as the
overall as well as the cardiovascular outcome related to the
findings of the study are not known. However, the collection
of information on all-cause mortality as well as cardio-
vascular events is ongoing. Although the population studied
reflects rather accurately the typical hemodialysis population
of North America, the high prevalence of diabetic patients
and African American individuals should caution against the
direct application of this information to populations of other
continents.
Table 2 | Test properties, likelihood ratios, and area under the curve associated with PP, valve, and abdominal aorta
calcification predicting the presence of CACS
Sensitivity (%) Specificity (%) Likelihood ratio Area under curve
Outcome – CACSX30
Pulse pressure 0.50
Quartile 2 49 41 0.83 (0.53, 1.30)
Quartile 3 45 43 0.78 (0.48, 1.27)
Quartile 4 50 53 1.06 (0.60, 1.88)
Calcified valves 0.58
1 46 65 1.32 (0.78, 2.21)
2 42 73 1.56 (0.81, 3.01)
Abdominal aorta calcification 0.78
Abdominal X-ray 1–6 54 78 2.47 (1.33, 4.61)
Abdominal X-ray 7–24 59 97 19.5 (2.80, 136)
Outcome – CACSX100
Pulse pressure 0.51
Quartile 2 48 42 0.82 (0.53, 1.27)
Quartile 3 44 45 0.79 (0.49, 1.28)
Quartile 4 51 54 1.12 (0.66, 1.88)
Calcified valves 0.62
1 53 70 1.79 (1.09, 2.96)
2 47 75 1.88 (1.05, 3.39)
Abdominal aorta calcification 0.78
Abdominal X-ray 1–6 61 76 2.53 (1.49, 4.28)
Abdominal X-ray 7–24 67 91 7.50 (2.89, 19.5)
Outcome – CACSX400
Pulse pressure 0.71
Quartile 2 46 45 0.83 (0.51, 1.36)
Quartile 3 52 54 1.12 (0.69, 1.83)
Quartile 4 50 51 1.03 (0.63, 1.37)
Calcified valves 0.63
1 59 66 1.76 (1.15, 2.69)
2 55 73 1.99 (1.19, 3.32)
Abdominal aorta calcification 0.74
Abdominal X-ray 1–6 64 68 2.01 (1.30, 3.11)
Abdominal X-ray 7–24 73 79 3.48 (2.07, 5.86)
Outcome – CACSX1000
Pulse pressure 0.48
Quartile 2 33 44 0.60 (0.26, 1.37)
Quartile 3 56 54 1.21 (0.73, 2.01)
Quartile 4 47 50 0.93 (0.51, 1.71)
Calcified valves 0.72
1 73 62 1.94 (1.30, 2.91)
2 78 73 2.85 (1.84, 4.43)
Abdominal aorta calcification 0.72
Abdominal X-ray 1–6 69 63 1.88 (1.19, 2.97)
Abdominal X-ray 7–24 80 70 2.63 (1.77, 3.93)
CACS, coronary artery calcium score; NPV, negative predictive value; PP, pulse pressure; PPV, positive predictive value.
Parentheses indicate 95% confidence intervals.
Abdominal X-ray scores were calculated according to the scoring methodology proposed by Kauppila et al.12 (range: 0–24).
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Conclusion
We have shown a very good correlation between simple
markers of cardiovascular calcification proposed by the
Global Bone and Mineral Initiative Executive Committee11
and the more sensitive, quantitative assessments of coronary
calcification obtainable with CT. Screening hemodialysis
patients for the presence of cardiovascular calcification with
these less expensive and more readily available modalities will
allow the practicing nephrologist to identify, with acceptable
accuracy, patients at higher risk for cardiovascular events. In
these patients, therapies directed at management of bone and
mineral metabolism should be carefully modified according
to guidelines.
MATERIALS AND METHODS
Patient selection
One hundred and forty-eight adult hemodialysis patients were
recruited from two centers in the US (Denver, CO and New Orleans,
LA, USA). Patients were selected if they had a history of chronic
kidney disease treated with maintenance hemodialysis and were able
to sign an informed consent. Patients were excluded if they were
pregnant or planning a pregnancy within the next 6 months, or had
undergone prior coronary artery bypass surgery, or coronary artery
stent placement to avoid metal artifacts on EBT imaging. They were
further excluded for active atrial fibrillation or a weight over 300
pounds. The latter two exclusions criteria were adopted because of
the weight limit of the EBT radiological cradle and to reduce
imaging artifact owing to an irregular heart rhythm. Of the 148
enrolled participants, four were excluded from the current analysis
for not having undergone an echocardiogram and an additional four
for not having undergone the lateral lumbar X-ray. After these
exclusions, the final sample size for the current study was 140
participants. All imaging tests were sent to a central laboratory
where each investigator was assigned an interpretation task
according to his/her own area of expertise. All tests (presence of
valvular calcification, abdominal aorta scores, and coronary artery
scores) were evaluated in a blinded manner by observers who were
unaware of the patients’ other test results.
EBT imaging
All EBT scans were performed using a C-150 scanner (GE-Imatron,
San Francisco, CA, USA). A standard imaging protocol was used and
45–60 contiguous tomographic slices were obtained at end-
expiration starting 0.5 cm above the aortic arch and extending to
the diaphragm. The slice thickness was kept at 3 mm and the
acquisition time at 100 msec per slice. A CACS for each area of
interest identified along the course of the coronary arteries was
calculated as originally described by Agatston et al.2 The CACS
contains information about the size and density of a calcified focus,
therefore incorporating information about the extent as well as the
severity of calcification. Total CACSs were estimated as the sum of
all individual scores in the territories of interest. All scans were
reviewed by a single experienced investigator (PR) to eliminate any
inter-reader variability. The intra-reader variability was tested
several times and was consistently below 5%. Scans were performed
only once in each patient. This was carried out because the
investigators at the two clinical sites used a well-established
technique that has been applied in several previous studies and felt
confident that there was no need to perform two consecutive
studies. Furthermore, two sets of CT scans would have exposed the
patients to an excessive dose of radiation considering the need for
every patient to also undergo an abdominal X-ray. The reported
interscan variability for the Agatston score is about 8–10%.23
Abdominal aorta plain roentgenography
A technique similar to that described by Kauppila et al.12 was
employed to obtain images of the lower abdominal aorta. This
technique was utilized in prior prospective studies that demon-
strated the prognostic significance of calcification of the aorta
detected by plain X-ray of the lower abdomen.12,24 In brief, a lateral
plain radiograph of the abdomen was obtained that included the last
two thoracic vertebrae and the first two sacral vertebrae. The aorta
was identified as the tubular structure coursing in front of the
anterior surface of the spine. A semiquantitative scoring system was
utilized as suggested in the original manuscript by Kauppila et al.12
Only the segments of abdominal aorta in front of the first to the
fourth lumbar vertebra were considered. Points were assigned from
1–3 (1: small; 2 moderate; 3: large) according to the length of each
calcified plaque identified along the anterior and posterior profile of
the aorta in front of each of the lumbar vertebrae taken into
consideration. With this numerical grading, the score could vary
from a minimum of 0 to a maximum of 24 points. All X-rays were
read by two investigators (EF and AB) and consensus was reached
on the interpretation of all radiographs.
Echocardiography
Two dimensional echocardiographic studies were performed utiliz-
ing a Sequoia 512 (Siemens, Erlangen, Germany) or Vivid 7
(General Electric, Milwaukee, WI, USA) system at either investiga-
tional site. Digital images were acquired in the long axis and short
axis parasternal views and the apical four and two chamber views
and three-cycle clips were stored on magnetic optical disks for future
review. The presence of valvular calcification (aortic and mitral
valve, separately) was performed visually and limited to the
assessment of presence vs absence of disease without any
quantification tool. All echocardiograms were read by two
experienced investigators (PR and AB) and consensus was reached
on the interpretation of all echocardiograms.
PP
PP was obtained in the supine position after 15–20 min rest and was
measured from the arm that did not contain an arterio-venous
fistula or a shunt. Arterial blood pressure was measured by means of
a manual sphygmomanometer and PP was assessed as the difference
between peak systolic and trough diastolic arterial pressure.
Statistical analysis
The study population characteristics were analyzed based on CACS
thresholds identified as clinically useful in the general population. A
CACSX30 on EBT has been shown to be highly reproducible and is
therefore clinically relevant as far as accuracy of EBT measurements.
On the contrary, scores X100, X400, and X1000 have all been
reported to be associated with increased morbidity and mortality in
the general population. Characteristics of the study population were
determined by CACS categories as mean and s.d. if normally
distributed or as median and inter-quartile range for variables with
skewed distributions for continuous variables (e.g., age), and
percentages, for dichotomous variables (e.g., diabetes mellitus).
Linear trends in these variables across the five categories of CACS
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were ascertained using least squares and maximum likelihood. The
prevalence of CACSX30, X100, X400, X1000, was calculated for
persons with and without aortic valve calcification, mitral valve
calcification, by quartile of PP, and abdominal aorta calcification
score, separately. The abdominal aorta calcification score was
divided into approximate tertiles (scores of 0, 1–6, and X7). This
was performed because 44% of the study population had scores of 0
and they were therefore kept in the same group rather than splitting
the population in exact tertiles. Further, we ascertained the
sensitivity and specificity of PP, aortic valve calcification, mitral
valve calcification, and abdominal aorta calcification scores to
predict various CACS. Additionally, we determined the diagnostic
capability of PP, aortic valve calcification, mitral valve calcification,
and abdominal aorta calcification to predict CACSX30, X100,
X400, X1000 by calculating likelihood ratios.25 Receiver operator
characteristic curves were used to determine the area under the
curve for each of these testing procedures.
All analyses were conducted using Stata 8.0 Statistical Software
(College Station, TX, USA).
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